APO RESEARCH · REPORT
Enzyme-Linked Immunosorbent Assay (ELISA)
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Product & engineering
Understand the product.
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Selected research
Industry Research
Enzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2026
Market perspective
ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
Read the full market overview
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
Report Scope
This report quantifies the global Enzyme-Linked Immunosorbent Assay (ELISA) market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Enzyme-Linked Immunosorbent Assay (ELISA).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Enzyme-Linked Immunosorbent Assay (ELISA) Market by Company
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sandwich ELISA
- Indirect ELISA
- Competitive ELISA
- Others
Applications
- Immunology
- Inflammation
- Infectious Diseases
- Cancer
- Protein Quantitation
- Others
Companies covered
- R&D Systems
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BD Biosciences
- ZEUS Scientific
- Bio-Rad Laboratories
- ALPCO
- Enzo Life Sciences
- BioMérieux
- EMD Millipore
- BioLegend
- LOEWE Biochemica
- Mercodia
- Cusabio
- Shanghai Kehua Bio-engineering
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sandwich ELISA
- 2.2.3 Indirect ELISA
- 2.2.4 Competitive ELISA
- 2.2.5 Others
- 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Immunology
- 2.3.3 Inflammation
- 2.3.4 Infectious Diseases
- 2.3.5 Cancer
- 2.3.6 Protein Quantitation
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Type
- 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Type (2021-2026)
- 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Type (2027-2032)
4 Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Application
- 4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Application (2021-2026)
- 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Perspective (2021-2032)
- 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Growth Trends by Region
- 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Region (2021-2026)
- 5.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Region (2027-2032)
- 5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
- 5.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
- 5.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
- 5.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
- 5.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Players by Revenue
- 6.1.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Players by Revenue (2021-2026)
- 6.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Players (2021-2026)
- 6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Enzyme-Linked Immunosorbent Assay (ELISA) Head Office and Area Served
- 6.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players, Product Type & Application
- 6.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Manufacturers Established Date
- 6.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
- 7.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
- 7.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
- 8.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
- 8.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
- 9.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
- 10.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
- 10.4 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
- 11.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 R&D Systems
- 12.1.1 R&D Systems Company Information
- 12.1.2 R&D Systems Business Overview
- 12.1.3 R&D Systems Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.1.5 R&D Systems Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Ortho Clinical Diagnostics
- 12.3.1 Ortho Clinical Diagnostics Company Information
- 12.3.2 Ortho Clinical Diagnostics Business Overview
- 12.3.3 Ortho Clinical Diagnostics Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.3.5 Ortho Clinical Diagnostics Recent Developments
- 12.4 BD Biosciences
- 12.4.1 BD Biosciences Company Information
- 12.4.2 BD Biosciences Business Overview
- 12.4.3 BD Biosciences Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.4.5 BD Biosciences Recent Developments
- 12.5 ZEUS Scientific
- 12.5.1 ZEUS Scientific Company Information
- 12.5.2 ZEUS Scientific Business Overview
- 12.5.3 ZEUS Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.5.5 ZEUS Scientific Recent Developments
- 12.6 Bio-Rad Laboratories
- 12.6.1 Bio-Rad Laboratories Company Information
- 12.6.2 Bio-Rad Laboratories Business Overview
- 12.6.3 Bio-Rad Laboratories Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.6.5 Bio-Rad Laboratories Recent Developments
- 12.7 ALPCO
- 12.7.1 ALPCO Company Information
- 12.7.2 ALPCO Business Overview
- 12.7.3 ALPCO Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.7.5 ALPCO Recent Developments
- 12.8 Enzo Life Sciences
- 12.8.1 Enzo Life Sciences Company Information
- 12.8.2 Enzo Life Sciences Business Overview
- 12.8.3 Enzo Life Sciences Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.8.5 Enzo Life Sciences Recent Developments
- 12.9 BioMérieux
- 12.9.1 BioMérieux Company Information
- 12.9.2 BioMérieux Business Overview
- 12.9.3 BioMérieux Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.9.5 BioMérieux Recent Developments
- 12.10 EMD Millipore
- 12.10.1 EMD Millipore Company Information
- 12.10.2 EMD Millipore Business Overview
- 12.10.3 EMD Millipore Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.10.5 EMD Millipore Recent Developments
- 12.11 BioLegend
- 12.11.1 BioLegend Company Information
- 12.11.2 BioLegend Business Overview
- 12.11.3 BioLegend Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.11.5 BioLegend Recent Developments
- 12.12 LOEWE Biochemica
- 12.12.1 LOEWE Biochemica Company Information
- 12.12.2 LOEWE Biochemica Business Overview
- 12.12.3 LOEWE Biochemica Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.12.5 LOEWE Biochemica Recent Developments
- 12.13 Mercodia
- 12.13.1 Mercodia Company Information
- 12.13.2 Mercodia Business Overview
- 12.13.3 Mercodia Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.13.5 Mercodia Recent Developments
- 12.14 Cusabio
- 12.14.1 Cusabio Company Information
- 12.14.2 Cusabio Business Overview
- 12.14.3 Cusabio Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.14.5 Cusabio Recent Developments
- 12.15 Shanghai Kehua Bio-engineering
- 12.15.1 Shanghai Kehua Bio-engineering Company Information
- 12.15.2 Shanghai Kehua Bio-engineering Business Overview
- 12.15.3 Shanghai Kehua Bio-engineering Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2021-2026)
- 12.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
- 12.15.5 Shanghai Kehua Bio-engineering Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst